STXS Key Stats
|Revenue (Quarterly YoY Growth)||-6.40%|
|EPS Diluted (TTM)||-6.022|
|EPS Diluted (Quarterly YoY Growth)|
|Net Income (TTM)||-69.11M|
|Gross Profit Margin (Quarterly)||67.66%|
|Profit Margin (Quarterly)||-525.5%|
|Dividend Yield (TTM)||0.00%|
|Payout Ratio (TTM) Pro||Go Pro|
- Stereotaxis to Present at Oppenheimer 24th Annual Healthcare Conference in New York on December 11, 2013 noodls Dec 6
- Stereotaxis (STXS) Files $75M Mixed Shelf Street Insider Nov 27
- STEREOTAXIS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Nov 27
- Stereotaxis Announces Results of Rights Offering noodls Nov 27
- Stereotaxis Rights Offering Expires November 21, 2013 noodls Nov 20
- STEREOTAXIS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Nov 20
- Stereotaxis, Inc. (STXS) Reports Q3 Loss of $0.26 Street Insider Nov 14
- Stereotaxis (STXS) Is Today's Perilous Reversal Stock Oct 24
- Stereotaxis (STXS) Reports Prelim. Q3 Revs of $10.6M - $11.1M Street Insider Oct 23
- Stereotaxis (STXS) Receives C2 Classification from Japan's MHLW for Niobe MNS Street Insider Oct 23
STXS Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Stereotaxis is up 139.8% over the last year vs S&P 500 Total Return up 30.43%, Boston Scientific up 112.0%, and Edwards Lifesciences down 27.25%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Balance Sheet View Statement
Pro Ratings for STXS
Pro Strategies Featuring STXS
Did Stereotaxis make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
Stereotaxis, Inc. designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital’s interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease.